Establishment of a High-Throughput Screening System for Caspase-3 Inhibitors

  • Park, Seung-Yong (Department of Veterinary Medicine, Konkuk University, Pharmaceutical Screening Research Laboratory, Korea Research Institute of Chemical Technology) ;
  • Park, Song-Hee (Pharmaceutical Screening Research Laboratory, Korea Research Institute of Chemical Technology) ;
  • Lee, Il-Sun (Pharmaceutical Screening Research Laboratory, Korea Research Institute of Chemical Technology) ;
  • Kong, Jae-Yang (Pharmaceutical Screening Research Laboratory, Korea Research Institute of Chemical Technology)
  • Published : 2000.06.01

Abstract

In most tissues, apoptosis plays a pivotal role in normal development and for regulating cell number, thus inappropriate apoptosis underlies a variety of diseases. Caspase-3 is one of a family of caspases that are mainly involved in the apoptotic signal transduction pathway, where caspase-3 acts as an effect molecule to proteolytically cleave intracellular substrates that are necessary for maintaining cell survival. Recent evidences show that apoptotic cell death can be blocked by inhibiting caspase-3, suggesting its inhibitors have potential to be therapeutic drugs for the diseases related with inappropriate apoptosis. We have established a screening system to search caspase-3 inhibitors from chemical libraries stocked in our institute. The enzyme assay is configured entirely in 96-well format, which is easily adapted for high throughput screening. Before performing mass screening, 80 in-house compounds were screened as a preliminary experiment, and we found that morin hydrate inhibited caspase-3 by 66.4 % at the final concentration of 20 ${\mu}g/m{\ell}$.

Keywords